MYC: A Stratification Marker for Pancreatic Cancer Therapy.
One approach to improve cancer treatment is to stratify patients and to develop subgroup-specific therapies. We will discuss the potential of MYC as a stratification marker in pancreatic ductal adenocarcinoma. Furthermore, we will point to possibilities for how to annotate the MYC status and how to target MYC-associated vulnerabilities.